{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:09:34Z","timestamp":1781629774303,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["G102199"],"award-info":[{"award-number":["G102199"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["G102199"],"award-info":[{"award-number":["G102199"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Autism Research Trust"},{"name":"Cambridgeshire and Peterborough NHS Foundation Trust","award":["G102307"],"award-info":[{"award-number":["G102307"]}]},{"name":"Cambridgeshire and Peterborough NHS Foundation Trust","award":["G102307"],"award-info":[{"award-number":["G102307"]}]},{"name":"Autism Action"},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024749","name":"National Institute for Health Research Applied Research Collaboration East of England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024749","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Applied Research Collaboration East of England, United Kingdom"},{"DOI":"10.13039\/100014370","name":"Simons Foundation Autism Research Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214322\\Z\\18\\Z"],"award-info":[{"award-number":["214322\\Z\\18\\Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["777394"],"award-info":[{"award-number":["777394"]}]},{"DOI":"10.13039\/501100011730","name":"Templeton World Charity Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autistic people experience increased health vulnerability and risk of premature mortality; the Covid-19 pandemic posed a serious health risk globally. The present study estimated risks of (i) first hospitalization, (ii) first hospitalization with a positive Covid-19 test, (iii) all-cause death, and (iv) Covid-19 associated death from 1 January 2020\u201331 March 2021 among autistic people compared to matched peers in England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We leveraged National Health Service records from 45,756 individuals, including 15,252 autistic individuals, via the Clinical Practice Research Datalink. Participants were matched 1:2 on birth year (\u00b1\u20092 years), gender, and general practitioner practice to 30,504 non-autistic people. The sample primarily comprised males and younger individuals, with a median age of 19.0 years (IQR\u2009=\u200912.0 years), which was expected based on the demographics of clinically diagnosed autistic people. For all outcomes, cox proportional hazards regression models were performed, accounting for matching criteria of gender, birth year, and clustering across GP practices. Additional models adjusting for matching criteria, as well as socioeconomic status, intellectual disability, obesity, alcohol misuse, and smoking were performed to assess risks of all-cause and Covid-19 related hospitalizations. However, due to perfect separation, it was not possible to conduct analyses for mortality that were adjusted for additional covariates (beyond matching factors), and Covid-19 related mortality modelling only assessed risk for male individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Autistic individuals had increased likelihood of all-cause hospitalization (HR: 1.32, 95% CI: 1.22\u20131.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001) compared to matched peers, even after adjusting for intellectual disability, obesity, alcohol misuse, smoking, socioeconomic status, and matching factors. Autistic individuals had increased risk of Covid-19 related hospitalizations compared to matched non-autistic individuals when only accounting for matching factors; however, after adjusting for additional covariates of interest, autism did not remain a significant predictor of Covid-19 related hospitalization. In addition, while only models adjusting for matching factors could be performed, the results provide some evidence of heightened all-cause mortality risk for autistic individuals compared to matched non-autistic individuals during the covid period (HR\u2009=\u20092.47, 95% CI: 1.31\u20134.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.005) and was inconclusive for Covid-19 associated deaths due to sparse events (HR\u2009=\u20091.26, 95% CI: 0.15\u20134.14,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.79).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>The study included a relatively young sample; thus, these results may be less applicable to older individuals and may underestimate effects for older individuals, as increasing age is a well-established risk factor for severe disease due to Covid-19 infection. In addition, due to low counts, analyses for mortality could only be adjusted for matching factors and the Covid-19 mortality analysis could only be conducted among males. Due to the nature of historically collected clinical data, we could not account for all potential confounders (e.g., residence type) and cannot eliminate the possibilities of missingness and\/or provider differences in clinical coding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Autistic young people had increased risks of all-cause hospitalization, with some evidence of increased risks of Covid-19 related hospitalization and all-cause death, during the first 15 months of the Covid-19 pandemic compared to matched non-autistic young people. The study bolsters existing evidence of increased health vulnerability among autistic people, including within the Covid-19 period; however, the results do not provide clarity on whether autism remains an independent predictor of Covid-19 related hospitalization or death. These findings provide the first targeted, clinically-representative, and UK-specific statistics on the health vulnerability of autistic young people during the Covid-19 pandemic, and this issue must be addressed in individual patient care, as well as national and international public health policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13229-025-00698-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:09:08Z","timestamp":1768226948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of hospitalization and death among autistic young people in England during the Covid-19 pandemic"],"prefix":"10.1186","volume":"17","author":[{"given":"Brigid Saoirse","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Fysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Tsompanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert A.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Baron-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"698_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [Internet]. American Psychiatric Association. 2013. https:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1362361315588200","volume":"20","author":"L Kenny","year":"2016","unstructured":"Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E. Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2016;20:442\u201362.","journal-title":"Autism"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/13623613221117914","volume":"27","author":"R Buijsman","year":"2023","unstructured":"Buijsman R, Begeer S, Scheeren AM. Autistic person\u2019 or \u2018person with autism\u2019? Person-first Language preference in Dutch adults with autism and parents. Autism. 2023;27:788\u201395.","journal-title":"Autism"},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2215-0366(19)30289-5","volume":"6","author":"MC Lai","year":"2019","unstructured":"Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: A systematic review and meta-analysis. Lancet Psychiatry. 2019;6:819\u201329. https:\/\/doi.org\/10.1016\/S2215-0366(19)30289-5.","journal-title":"Lancet Psychiatry"},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/acps.13368","volume":"144","author":"MB Posserud","year":"2021","unstructured":"Posserud MB, Skretting Solberg B, Engeland A, Haavik J, Klungs\u00f8yr K. Male to female ratios in autism spectrum disorders by age, intellectual disability and attention-deficit\/hyperactivity disorder. Acta Psychiatr Scand. 2021;144:635\u201346.","journal-title":"Acta Psychiatr Scand"},{"key":"698_CR6","unstructured":"Shaw KA, Williams S, Patrick ME, Valencia-Prado M, Durkin MS, Howerton EM, et al. Prevalence and early identification of autism spectrum disorder aming children aged 4 and 8 years \u2014 autism and developmental disabilities monitoring network, 16 sites, United States, 2022. MMWR Surveill Summ. 2025;74:1\u201322. https:\/\/www.cdc.gov\/mmwr\/volumes\/74\/ss\/ss7402a1.htm. ."},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"100626","DOI":"10.1016\/j.lanepe.2023.100626","volume":"29","author":"E O\u2019Nions","year":"2023","unstructured":"O\u2019Nions E, Petersen I, Buckman JEJ, Charlton R, Cooper C, Corbett A, et al. Autism in england: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data. Lancet Reg Heal - Eur. 2023;29:100626. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100626.","journal-title":"Lancet Reg Heal - Eur"},{"key":"698_CR8","unstructured":"UK Health Security Agency. COVID-19 confirmed deaths in England (to 31 December 2022): Report [Internet]. COVID-19: reported SARS-CoV-2 deaths in England. 2023. https:\/\/www.gov.uk\/government\/publications\/covid-19-reported-sars-cov-2-deaths-in-england\/covid-19-confirmed-deaths-in-england-to-31-december-2022-report"},{"key":"698_CR9","unstructured":"UK Health Security Agency. UKHSA data series on deaths in people with COVID-19: technical summary [Internet]. Health and wellbeing during COVID-19. 2022. https:\/\/www.gov.uk\/government\/publications\/phe-data-series-on-deaths-in-people-with-covid-19-technical-summary?utm_source=dac7e433-2d30-42a4-9622-ba39a93af8d7%26utm_medium=email%26utm_campaign=govuk-notifications%26utm_content=immediate"},{"key":"698_CR10","unstructured":"National Health Service. Who is at high risk from coronavirus (COVID-19) [Internet]. People at higher risk from coronavirus (COVID-19). 2021. https:\/\/web.archive.org\/web\/20220102080403\/https:\/www.nhs.uk\/conditions\/coronavirus-covid-19\/people-at-higher-risk\/who-is-at-high-risk-from-coronavirus\/"},{"key":"698_CR11","first-page":"1","volume":"371","author":"AK Clift","year":"2020","unstructured":"Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: National derivation and validation cohort study. BMJ. 2020;371:1\u201320.","journal-title":"BMJ"},{"key":"698_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/1362361315577517","volume":"19","author":"LA Croen","year":"2015","unstructured":"Croen LA, Zerbo O, Qian Y, Massolo ML, Rich S, Sidney S, et al. The health status of adults on the autism spectrum. Autism. 2015;19:814\u201323.","journal-title":"Autism"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jamapediatrics.2022.5629","volume":"177","author":"CS Dhanasekara","year":"2023","unstructured":"Dhanasekara CS, Ancona D, Cortes L, Hu A, Rimu AH, Robohm-Leavitt C, et al. Association between autism spectrum disorders and cardiometabolic diseases: A systematic review and Meta-analysis. JAMA Pediatr. 2023;177:248\u201357.","journal-title":"JAMA Pediatr"},{"key":"698_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/1362361319890793","volume":"24","author":"BN Hand","year":"2020","unstructured":"Hand BN, Angell AM, Harris L, Carpenter LA. Prevalence of physical and mental health conditions in Medicare-enrolled, autistic older adults. Autism. 2020;24:755\u201364.","journal-title":"Autism"},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1192\/bjp.bp.114.160192","volume":"208","author":"T Hirvikoski","year":"2016","unstructured":"Hirvikoski T, Mittendorfer-Rutz E, Boman M, Larsson H, Lichtenstein P, B\u00f6lte S. Premature mortality in autism spectrum disorder. Br J Psychiatry. 2016;208:232\u20138.","journal-title":"Br J Psychiatry"},{"key":"698_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/13623613211039662","volume":"26","author":"W Schott","year":"2022","unstructured":"Schott W, Tao S, Shea L. COVID-19 risk: adult medicaid beneficiaries with autism, intellectual disability, and mental health conditions. Autism. 2022;26:975\u201387.","journal-title":"Autism"},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-023-00565-2","volume":"14","author":"JH Ward","year":"2023","unstructured":"Ward JH, Weir E, Allison C, Baron-Cohen S. Increased rates of chronic physical health conditions across all organ systems in autistic adolescents and adults. Mol Autism. 2023;14:1\u201320. https:\/\/doi.org\/10.1186\/s13229-023-00565-2.","journal-title":"Mol Autism"},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-021-00441-x","volume":"12","author":"E Weir","year":"2021","unstructured":"Weir E, Allison C, Ong KK, Baron-Cohen S. An investigation of the diet, exercise, sleep, BMI, and health outcomes of autistic adults. Mol Autism. 2021;12:1\u201314. https:\/\/doi.org\/10.1186\/s13229-021-00441-x.","journal-title":"Mol Autism"},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/1362361320953652","volume":"25","author":"E Weir","year":"2021","unstructured":"Weir E, Allison C, Warrier V, Baron-Cohen S. Increased prevalence of non-communicable physical health conditions among autistic adults. Autism. 2021;25:681\u201394.","journal-title":"Autism"},{"key":"698_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-022-00501-w","volume":"13","author":"E Weir","year":"2022","unstructured":"Weir E, Allison C, Baron-Cohen S. Autistic adults have poorer quality healthcare and worse health based on self-report data. Mol Autism. 2022;13:1\u201319. https:\/\/doi.org\/10.1186\/s13229-022-00501-w.","journal-title":"Mol Autism"},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10803-017-3292-0","volume":"48","author":"JA Weiss","year":"2018","unstructured":"Weiss JA, Isaacs B, Diepstra H, Wilton AS, Brown HK, McGarry C, et al. Health concerns and health service utilization in a population cohort of young adults with autism spectrum disorder. J Autism Dev Disord. 2018;48:36\u201344.","journal-title":"J Autism Dev Disord"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S2215-0366(21)00160-7","volume":"8","author":"E Weir","year":"2021","unstructured":"Weir E, Allison C, Baron-Cohen S. Understanding the substance use of autistic adolescents and adults: a mixed-methods approach. Lancet Psychiatry. 2021;8:673\u201385. https:\/\/doi.org\/10.1016\/S2215-0366(21)00160-7.","journal-title":"Lancet Psychiatry"},{"key":"698_CR23","doi-asserted-by":"publisher","unstructured":"Brown CM, Newell V, Sahin E, Hedley D. Updated systematic review of suicide in autism: 2018\u20132024. Curr Dev Disord Rep. 2024;225\u201356. https:\/\/doi.org\/10.1007\/s40474-024-00308-9.","DOI":"10.1007\/s40474-024-00308-9"},{"key":"698_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1001\/jamapsychiatry.2022.3475","volume":"79","author":"MI Martini","year":"2022","unstructured":"Martini MI, Kuja-Halkola R, Butwicka A, Du Rietz E, D\u2019Onofrio BM, Happ\u00e9 F, et al. Sex differences in mental health problems and psychiatric hospitalization in autistic young adults. JAMA Psychiatry. 2022;79:1188\u201398.","journal-title":"JAMA Psychiatry"},{"key":"698_CR25","first-page":"1726","volume":"76","author":"GR Stewart","year":"2021","unstructured":"Stewart GR, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, et al. The mental and physical health profiles of older adults who endorse elevated autistic traits. Journals Gerontol - Ser B Psychol Sci Soc Sci. 2021;76:1726\u201337.","journal-title":"Journals Gerontol - Ser B Psychol Sci Soc Sci"},{"key":"698_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-023-00548-3","volume":"14","author":"PY Pan","year":"2023","unstructured":"Pan PY, Taylor MJ, Larsson H, Almqvist C, Lichtenstein P, Lundstr\u00f6m S, et al. Genetic and environmental contributions to co-occurring physical health conditions in autism spectrum condition and attention-deficit\/hyperactivity disorder. Mol Autism. 2023;14:1\u201313. https:\/\/doi.org\/10.1186\/s13229-023-00548-3.","journal-title":"Mol Autism"},{"key":"698_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/aur.2872","volume":"16","author":"L Bishop","year":"2023","unstructured":"Bishop L, Charlton RA, McLean KJ, McQuaid GA, Lee NR, Wallace GL. Cardiovascular disease risk factors in autistic adults: the impact of sleep quality and antipsychotic medication use. Autism Res. 2023;16:569\u201379.","journal-title":"Autism Res"},{"key":"698_CR28","doi-asserted-by":"publisher","first-page":"104980","DOI":"10.1016\/j.ridd.2025.104980","volume":"161","author":"D Lee","year":"2025","unstructured":"Lee D, Kennedy J, Cothran DJ, Shih PC, Dickinson S, Golzarri-Arroyo L, et al. Correlates of physical activity, sedentary time, and cardiovascular disease risk factors in autistic adults without intellectual disabilities. Res Dev Disabil. 2025;161:104980. https:\/\/doi.org\/10.1016\/j.ridd.2025.104980.","journal-title":"Res Dev Disabil"},{"key":"698_CR29","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/aur.2162","volume":"12","author":"S Griffiths","year":"2019","unstructured":"Griffiths S, Allison C, Kenny R, Holt R, Smith P, Baron-Cohen S. The vulnerability experiences quotient (VEQ): A study of vulnerability, mental health and life satisfaction in autistic adults. Autism Res. 2019;12:1516\u201328.","journal-title":"Autism Res"},{"key":"698_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13229-025-00664-2","volume":"16","author":"SN Binte Mohd Ikhsan","year":"2025","unstructured":"Binte Mohd Ikhsan SN, Holt R, Man J, Parsons T, Schalbroeck R, Ruigrok A, et al. Access to services for autistic people across Europe. Mol Autism. 2025;16:35. https:\/\/doi.org\/10.1186\/s13229-025-00664-2. https:\/\/molecularautism.biomedcentral.com\/articles\/.","journal-title":"Mol Autism"},{"key":"698_CR31","doi-asserted-by":"publisher","first-page":"e056904","DOI":"10.1136\/bmjopen-2021-056904","volume":"12","author":"M Doherty","year":"2022","unstructured":"Doherty M, Neilson S, O\u2019Sullivan J, Carravallah L, Johnson M, Cullen W, et al. Barriers to healthcare and self-reported adverse outcomes for autistic adults: a cross-sectional study. BMJ Open. 2022;12:e056904. https:\/\/doi.org\/10.1136\/bmjopen-2021-056904. https:\/\/bmjopen.bmj.com\/lookup\/doi\/.","journal-title":"BMJ Open"},{"key":"698_CR32","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/13623613241298352","volume":"29","author":"LK McLay","year":"2025","unstructured":"McLay LK, Schluter PJ, Williams J, Anns F, Monk R, Dacombe J, et al. Health service utilization among autistic youth in Aotearoa new zealand: A nationwide cross-sectional study. Autism. 2025;29:1143\u201356.","journal-title":"Autism"},{"key":"698_CR33","unstructured":"Office for National Statistics. Outcomes for disabled people in the UK: 2021 [Internet]. Census 2021. 2022. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/disability\/articles\/outcomesfordisabledpeopleintheuk\/2021#education"},{"key":"698_CR34","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s10803-023-05971-2","volume":"54","author":"A Davis","year":"2024","unstructured":"Davis A, Van Eck K, Copeland-Linder N, Phuong K, Belcher HME. Hospitalization and mortality for insured patients in the united States with COVID-19 with and without autism spectrum disorder. J Autism Dev Disord. 2024;54:2347\u201354.","journal-title":"J Autism Dev Disord"},{"key":"698_CR35","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1007\/s10803-021-05100-x","volume":"52","author":"A Karpur","year":"2022","unstructured":"Karpur A, Vasudevan V, Shih A, Frazier T. Brief report: impact of COVID-19 in individuals with autism spectrum disorders: analysis of a National private claims insurance database. J Autism Dev Disord. 2022;52:2350\u20136. https:\/\/doi.org\/10.1007\/s10803-021-05100-x.","journal-title":"J Autism Dev Disord"},{"key":"698_CR36","doi-asserted-by":"publisher","first-page":"E2111182","DOI":"10.1001\/jamanetworkopen.2021.11182","volume":"4","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4:E2111182.","journal-title":"JAMA Netw Open"},{"key":"698_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijid.2022.01.038","volume":"116","author":"AK Koyama","year":"2022","unstructured":"Koyama AK, Koumans EH, Sircar K, Lavery A, Hsu J, Ryerson AB, et al. Severe outcomes, readmission, and length of stay among COVID-19 patients with intellectual and developmental disabilities. Int J Infect Dis. 2022;116:328\u201330. https:\/\/doi.org\/10.1016\/j.ijid.2022.01.038.","journal-title":"Int J Infect Dis"},{"key":"698_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10803-021-05187-2","volume":"53","author":"I Krieger","year":"2023","unstructured":"Krieger I, Erez G, Weinstein O, Cohen AD, Tzur Bitan D. COVID-19 morbidity among individuals with autistic spectrum disorder: A matched controlled population-based study. J Autism Dev Disord. 2023;53:789\u201394. https:\/\/doi.org\/10.1007\/s10803-021-05187-2.","journal-title":"J Autism Dev Disord"},{"key":"698_CR39","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1177\/13623613231160631","volume":"27","author":"J Yun","year":"2023","unstructured":"Yun J, Kang B, Lee JR, Lee H, Lee JY. Prevalence and severity of COVID-19 among children and adolescents with autism spectrum disorders in the Republic of Korea. Autism. 2023;27:2397\u2013406.","journal-title":"Autism"},{"key":"698_CR40","unstructured":"World Health Organization. The true death toll of COVID-19: Estimating global excess mortality [Internet]. https:\/\/www.who.int\/data\/stories\/the-true-death-toll-of-covid-19-estimating-global-excess-mortality"},{"key":"698_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-022-00536-z","volume":"14","author":"B Vibert","year":"2023","unstructured":"Vibert B, Segura P, Gallagher L, Georgiades S, Pervanidou P, Thurm A, et al. CRISIS AFAR: an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions. Mol Autism. 2023;14:1\u201317.","journal-title":"Mol Autism"},{"key":"698_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpsychires.2023.01.029","volume":"159","author":"A Shakeshaft","year":"2023","unstructured":"Shakeshaft A, Blakey R, Kwong ASF, Riglin L, Davey Smith G, Stergiakouli E, et al. Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders. J Psychiatr Res. 2023;159:230\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.01.029.","journal-title":"J Psychiatr Res"},{"key":"698_CR43","unstructured":"Medicine and Healthcare Products Regulatory Agency (MHRA). Hospital Episode Statistics (HES) Admitted Patient Care and CPRD primary care data Documentation (set 22\/January 2022). 2021;2:. https:\/\/www.cprd.com\/sites\/default\/files\/2024-11\/HES_APC_Documentation_v2.9.pdf"},{"key":"698_CR44","unstructured":"Medicine and Healthcare Products Regulatory Agency (MHRA). ONS death registration data and CPRD primary care data Documentation (set 22\/January 2022). 2022;1\u201311. https:\/\/cprd.com\/sites\/default\/files\/2022-02\/Documentation_Death_set22_v2.6.pdf"},{"key":"698_CR45","unstructured":"Office for National Statistics. English indices of deprivation 2015. Ministry of Housing, Communities & Local Government (2018 to 2021). 2015."},{"key":"698_CR46","unstructured":"Clinical Practice Research Datalink. CPRD GOLD June 2024. Clinical Practice Research Datalink; 2024."},{"key":"698_CR47","doi-asserted-by":"publisher","unstructured":"Cherskov A, Pohl A, Allison C, Zhang H, Payne RA, Baron-Cohen S. Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory. Transl Psychiatry. 2018;8. https:\/\/doi.org\/10.1038\/s41398-018-0186-7.","DOI":"10.1038\/s41398-018-0186-7"},{"key":"698_CR48","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamadermatol.2017.3225","volume":"153","author":"R Parisi","year":"2017","unstructured":"Parisi R, Webb RT, Carr MJ, Moriarty KJ, Elise Kleyn C, Griffiths CEM, et al. Alcohol-related mortality in patients with psoriasis a population-based cohort study. JAMA Dermatology. 2017;153:1256\u201362.","journal-title":"JAMA Dermatology"},{"key":"698_CR49","doi-asserted-by":"crossref","unstructured":"Reeves D, Springate DA, Ashcroft DM, Ryan R, Doran T, Morris R, et al. Can analyses of electronic patient records be independently and externally validated? The effect of Statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysis. BMJ Open. 2014;4.","DOI":"10.1136\/bmjopen-2014-004952"},{"key":"698_CR50","doi-asserted-by":"crossref","unstructured":"Tyrer F, Morriss R, Kiani R, Gangadharan SK, Kundaje H, Rutherford MJ. Health needs and their relationship with life expectancy in people with and without intellectual disabilities in England. Int J Environ Res Public Health. 2022;19.","DOI":"10.3390\/ijerph19116602"},{"key":"698_CR51","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(20)30854-0","volume":"395","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet. 2020;395:1715\u201325. https:\/\/doi.org\/10.1016\/S0140-6736(20)30854-0.","journal-title":"Lancet"},{"key":"698_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81451-w","volume":"11","author":"I De Toma","year":"2021","unstructured":"De Toma I, Dierssen M. Network analysis of down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci Rep. 2021;11:1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-81451-w.","journal-title":"Sci Rep"},{"key":"698_CR53","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","volume":"23","author":"L Malle","year":"2021","unstructured":"Malle L, Gao C, Hur C, Truong HQ, Bouvier NM, Percha B, et al. Individuals with down syndrome hospitalized with COVID-19 have more severe disease. Genet Med. 2021;23:576\u201380. https:\/\/doi.org\/10.1038\/s41436-020-01004-w.","journal-title":"Genet Med"},{"key":"698_CR54","first-page":"317","volume":"13","author":"JE Brandenburg","year":"2020","unstructured":"Brandenburg JE, Fogarty MJ, Sieck GC. Why individuals with cerebral palsy are at higher risk for respiratory complications from COVID-19. J Pediatr Rehabil Med. 2020;13:317\u201327.","journal-title":"J Pediatr Rehabil Med"},{"key":"698_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-35966-z","volume":"13","author":"CC Huang","year":"2023","unstructured":"Huang CC, Xu H. Individual-level precision diagnosis for coronavirus disease 2019 related severe outcome: an early study in new York. Sci Rep. 2023;13:1\u201310. https:\/\/doi.org\/10.1038\/s41598-023-35966-z.","journal-title":"Sci Rep"},{"key":"698_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prrv.2017.07.003","volume":"26","author":"HS Alsubie","year":"2018","unstructured":"Alsubie HS, Rosen D. The evaluation and management of respiratory disease in children with down syndrome (DS). Paediatr Respir Rev. 2018;26:49\u201354. https:\/\/doi.org\/10.1016\/j.prrv.2017.07.003.","journal-title":"Paediatr Respir Rev"},{"key":"698_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/13623613211022091","volume":"26","author":"T Simantov","year":"2022","unstructured":"Simantov T, Pohl A, Tsompanidis A, Weir E, Lombardo MV, Ruigrok A, et al. Medical symptoms and conditions in autistic women. Autism. 2022;26:373\u201388.","journal-title":"Autism"},{"key":"698_CR58","doi-asserted-by":"crossref","unstructured":"Torenvliet C, Radhoe TA, Geurts HM. Occurrence and overlap of physical and mental health conditions in autistic adults. Autism. 2025.","DOI":"10.1177\/13623613251362346"},{"key":"698_CR59","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/aur.2787","volume":"15","author":"AM Scheeren","year":"2022","unstructured":"Scheeren AM, Howlin P, Pellicano L, Magiati I, Begeer S. Continuity and change in loneliness and stress during the COVID-19 pandemic: A longitudinal study of autistic and non-autistic adults. Autism Res. 2022;15:1621\u201335.","journal-title":"Autism Res"},{"key":"698_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyaf077\/8160618","author":"MT Sanchez-Santos","year":"2025","unstructured":"Sanchez-Santos MT, Axson EL, Dedman D, Delmestri A. Data resource profile update: CPRD GOLD. Int J Epidemiol. 2025. https:\/\/doi.org\/10.1093\/ije\/dyaf077\/8160618. https:\/\/academic.oup.com\/ije\/article\/doi\/. 54:.","journal-title":"Int J Epidemiol"},{"key":"698_CR61","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336. https:\/\/doi.org\/10.1093\/ije\/dyv098. https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/.","journal-title":"Int J Epidemiol"},{"key":"698_CR62","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1038\/s41467-020-17794-1","volume":"11","author":"V Warrier","year":"2020","unstructured":"Warrier V, Greenberg DM, Weir E, Buckingham C, Smith P, Lai MC, et al. Elevated rates of autism, other neurodevelopmental and psychiatric diagnoses, and autistic traits in transgender and gender-diverse individuals. Nat Commun. 2020;11:3959. https:\/\/www.nature.com\/articles\/s41467-020-17794-1.","journal-title":"Nat Commun"},{"key":"698_CR63","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s10803-022-05517-y","volume":"53","author":"A Kallitsounaki","year":"2023","unstructured":"Kallitsounaki A, Williams DM. Autism spectrum disorder and gender dysphoria\/incongruence. A systematic literature review and meta-analysis. J Autism Dev Disord. 2023;53:3103\u201317. https:\/\/doi.org\/10.1007\/s10803-022-05517-y. https:\/\/link.springer.com\/.","journal-title":"J Autism Dev Disord"},{"key":"698_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CLEP.S191437","volume":"11","author":"I Petersen","year":"2019","unstructured":"Petersen I, Welch CA, Nazareth I, Walters K, Marston L, Morris RW, et al. Health indicator recording in UK primary care electronic health records: key implications for handling missing data. Clin Epidemiol. 2019;11:157\u201367.","journal-title":"Clin Epidemiol"},{"key":"698_CR65","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/jech-2022-219200","volume":"76","author":"P Mahadevan","year":"2022","unstructured":"Mahadevan P, Harley M, Fordyce S, Hodgson S, Ghosh R, Myles P, et al. Completeness and representativeness of small area socioeconomic data linked with the UK clinical practice research datalink (CPRD). J Epidemiol Community Health. 2022;76:880\u20136.","journal-title":"J Epidemiol Community Health"},{"key":"698_CR66","unstructured":"NHS England. Landmark moment as first NHS patient receives COVID-19 vaccination [Internet]. News. 2020. https:\/\/www.england.nhs.uk\/2020\/12\/landmark-moment-as-first-nhs-patient-receives-covid-19-vaccination\/"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-025-00698-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00698-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00698-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:37:38Z","timestamp":1781627858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13229-025-00698-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s13229-025-00698-6","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was confirmed as part of the ISAC protocol application submission. We received initial ISAC approval from the MHRA Independent Scientific Advisory Committee for protocol 20_000067 on November 13th, 2020 and access to linked Covid-19 data was confirmed via post-approval amendments. CPRD utilizes retrospective, routinely collected National Health Service data for pre-approved public health research purposes only. Patients cannot be identified based on the data that CPRD receives from GP practices, and individual GP practices choose whether or not to share patient data with CPRD. Individual patients are able to opt-out of sharing their data for research; in cases where patients opt-out, CPRD does not collect data for these patients. As noted above, access to CPRD data is only available to researchers with an approved protocol and ethical approval is included in protocol consideration. The Royal College of GPs and the British Medical Association are both supportive of GP practices sharing their data with CPRD. Further information can be found at:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Sir Simon Baron-Cohen was a founding co-Editor-in-Chief of Molecular Autism. The authors have no other conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}